Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan

NACompletedINTERVENTIONAL
Enrollment

801

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
NASH - Nonalcoholic SteatohepatitisNAFLDMetabolic Syndrome
Interventions
DIAGNOSTIC_TEST

LiverMultiScan

LiverMultiScan is an imaging technique which is able to identify early liver disease.

Trial Locations (11)

2333

Leiden University Medical Center, Leiden

89081

University Hospital Ulm, Ulm

3004-531

University of Coimbra, Coimbra

SO16 6YD

Southampton University Hospital, Southampton

L9 7AL

Aintree Hospital, Liverpool

DD2 1SG

Ninewells Hospital, Dundee

EH16 4SA

Royal Infirmary of Edinburgh, Edinburgh

G40SF

Glasgow Royal Infirmary, Glasgow

G51 4TF

Queen Elizabeth University Hospital, Glasgow

SE5 9RS

King's College Hospital, London

SW170Q2

St George's Hospital, London

All Listed Sponsors
collaborator

University of Coimbra

OTHER

collaborator

University Hospital Ulm

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

collaborator

King's College Hospital NHS Trust

OTHER

collaborator

NHS Greater Glasgow and Clyde

OTHER

collaborator

Glasgow Royal Infirmary

OTHER

collaborator

Ninewells Hospital

OTHER

collaborator

Royal Infirmary of Edinburgh

OTHER

collaborator

St George's University Hospitals NHS Foundation Trust

OTHER

lead

Perspectum

INDUSTRY

NCT03289897 - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan | Biotech Hunter | Biotech Hunter